A SARS-CoV-2 entry inhibitor trimerizes to lock the spike trimer in its closed conformation
Mou, H., Gao, B., Ye, G., Bu, F., Zhang, L., Farzan, M., Li, F., Choe, H.To be published.
Experimental Data Snapshot
wwPDB Validation 3D Report Full Report
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Spike glycoprotein | 1,252 | Severe acute respiratory syndrome coronavirus 2 | Mutation(s): 0  Gene Names: S, 2 | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P0DTC2 | ||||
Glycosylation | |||||
| Glycosylation Sites: 9 | Go to GlyGen: P0DTC2-1 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Ligands 2 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| A1CZB Download:Ideal Coordinates CCD File | N [auth A], W [auth B], X [auth B] | N-{4-[(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}naphthalene-1-carboxamide C21 H18 N4 O3 S2 HJZPZKJJQGFFBQ-UHFFFAOYSA-N | |||
| NAG (Subject of Investigation/LOI) Download:Ideal Coordinates CCD File | AA [auth C] BA [auth C] CA [auth C] DA [auth C] EA [auth C] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
| Task | Software Package | Version |
|---|---|---|
| RECONSTRUCTION | cryoSPARC | 4.5.1 |
| MODEL REFINEMENT | PHENIX | 1.16 |
| Funding Organization | Location | Grant Number |
|---|---|---|
| National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | U19AI171954 |